OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive Mendelian randomization study
Jiarong Xie, Hangkai Huang, Zhening Liu, et al.
Hepatology (2022) Vol. 77, Iss. 3, pp. 949-964
Open Access | Times Cited: 163

Showing 1-25 of 163 citing articles:

Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease
Ziang Li, Bin Zhang, Qing‐Rong Liu, et al.
EBioMedicine (2023) Vol. 90, pp. 104543-104543
Open Access | Times Cited: 83

Insights into modifiable risk factors of erectile dysfunction, a wide-angled Mendelian Randomization study
Yang Xiong, Fuxun Zhang, Yangchang Zhang, et al.
Journal of Advanced Research (2023) Vol. 58, pp. 149-161
Open Access | Times Cited: 46

Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases
Reddemma Sandireddy, Suganya Sakthivel, Priyanka Gupta, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 26

The impact of obesity: a narrative review
Benjamin Chih Chiang Lam, Amanda Yuan Ling Lim, Soo Ling Chan, et al.
Singapore Medical Journal (2023) Vol. 64, Iss. 3, pp. 163-171
Open Access | Times Cited: 39

Investigating causal associations among gut microbiota, metabolites, and liver diseases: a Mendelian randomization study
Lilong Zhang, Liuliu Zi, Tianrui Kuang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 24

NAFLD: An Emerging Causal Factor for Cardiovascular Disease
Mei Li, Horng‐Dar Wang, Xiao‐Jing Zhang, et al.
Physiology (2023) Vol. 38, Iss. 6, pp. 255-265
Closed Access | Times Cited: 24

Thyroid hormone receptor-β analogs for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Vlad Ratziu, Thomas S. Scanlan, Eveline Bruinstroop
Journal of Hepatology (2024)
Open Access | Times Cited: 11

Association of metabolic signatures of air pollution with MASLD: Observational and Mendelian randomization study
Shanshan Ran, Jingyi Zhang, Fei Tian, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 9

Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis
Alessandro Mantovani, Alessandro Csermely, Josh Bilson, et al.
Gut (2024) Vol. 73, Iss. 9, pp. 1554-1561
Closed Access | Times Cited: 8

Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease
Xiangyong Hao, Hao Song, Xin Su, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access | Times Cited: 1

Impact of Education on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Southern Italy Cohort-Based Study
Rossella Donghia, Caterina Bonfiglio, Gianluigi Giannelli, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1950-1950
Open Access | Times Cited: 1

Machine learning for predicting metabolic-associated fatty liver disease including NHHR: a cross-sectional NHANES study
Liyu Lin, Yirui Xie, Zhuangteng Lin, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0319851-e0319851
Open Access | Times Cited: 1

Phosphodiesterase and psychiatric disorders: a two-sample Mendelian randomization study
Miaomiao Jiang, Weiheng Yan, Yuyanan Zhang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 20

The associations between gut microbiota and chronic respiratory diseases: a Mendelian randomization study
Hanyu Shi, Tong Zhao, RuiHui Geng, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 19

Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk
Tianyi Xia, Mulong Du, Huiqin Li, et al.
Radiology (2023) Vol. 309, Iss. 1
Closed Access | Times Cited: 18

Associations between type 1 diabetes and pulmonary tuberculosis: a bidirectional mendelian randomization study
Yijia Jiang, Wen‐Hua Zhang, Maoying Wei, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 7

Extrahepatic malignancies in metabolic dysfunction‐associated fatty liver disease: A nationwide cohort study
Min Kyung Park, Moon Haeng Hur, Hye‐Sung Moon, et al.
Liver International (2024) Vol. 44, Iss. 3, pp. 799-810
Closed Access | Times Cited: 6

Causal relationship between cannabis use and cancer: a genetically informed perspective
Peng Huang, Pengfei Zhang, Qiu Li
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 8631-8638
Closed Access | Times Cited: 15

The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease
Zhenhua Yang, Awang Danzeng, Qiumeng Liu, et al.
International Journal of Biological Sciences (2023) Vol. 20, Iss. 1, pp. 113-126
Open Access | Times Cited: 15

Causal association between colorectal cancer and Alzheimer’s disease: a bidirectional two-sample mendelian randomization study
Chunsheng Yuan, Saisai Liu, Kezhen Yang, et al.
Frontiers in Genetics (2024) Vol. 14
Open Access | Times Cited: 5

Liraglutide Improves Nonalcoholic Fatty Liver Disease in Diabetic Mice by Activating Autophagy Through AMPK/mTOR Signaling Pathway
Zhanlin Liao, Liangzhi Huang, Jun Chen, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 575-584
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top